Circulation, Vol 88, 1470-1475, Copyright © 1993 by American Heart Association
BD McCallister Jr, TF Christian, BJ Gersh and RJ Gibbons
BACKGROUND. Prior studies based on autopsy data suggest that infarction of
more than 40% of the left ventricle necessitates cardiogenic shock and
death. METHODS AND RESULTS. Technetium-99m Sestamibi tomography was used
prospectively to measure infarct size at discharge in 166 patients with
acute myocardial infarction. Patients with previous myocardial infarction
or revascularization were excluded from the trial. Sixteen patients were
identified with final infarct sizes > 40% of the left ventricle despite
acute reperfusion therapy. These 16 patients (13 men) had a mean age of 63
+/- 10 years; 44% had a previous history of angina. Ten patients had
emergent coronary angioplasty only (mean time to percutaneous transluminal
coronary angioplasty [PTCA], 6.0 +/- 3.0 hours); 6 had thrombolysis (mean
time to tissue plasminogen activator, 4.0 +/- 1.5 hours), of which 2 had
rescue PTCA (5 and 3 hours from onset of pain). Of 15 patients who had
angiograms after therapy, 15 had open infarct-related arteries. The left
anterior descending artery was the infarct-related artery in 14 (9 proximal
and 5 distal lesions). Half the patients had only single-vessel disease.
Infarct size measured 50 +/- 7% of the left ventricle (range, 42% to 68%).
Ejection fraction by radionuclide angiogram was 0.33 +/- 0.09 and 0.38 +/-
0.07 at discharge and 6 weeks, respectively. Hospital complications
included shock (1 patient), pulmonary edema (2), angina (3), symptomatic
nonsustained ventricular tachycardia (1), transient complete heart block
(2), and transient bifascicular block (1). At follow-up (13 +/- 9 months),
the patient with shock had died, but the remaining 15 patients were
asymptomatic (1 had late PTCA for angina). CONCLUSIONS. In the
interventional and thrombolytic era, patients with large residual
myocardial infarctions can survive without heart failure.
ARTICLES
Prognosis of myocardial infarctions involving more than 40% of the left ventricle after acute reperfusion therapy
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn. 55905.
This article has been cited by other articles:
![]() |
G. Ndrepepa, A. Kastrati, F.-J. Neumann, C. Schmitt, J. Mehilli, and A. Schomig Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting Eur. Heart J., September 2, 2004; 25(18): 1635 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakuma, Y. Hayashi, K. Sumii, M. Imazu, and M. Yamakido Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization J. Am. Coll. Cardiol., October 1, 1998; 32(4): 890 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality Circulation, August 1, 1995; 92(3): 334 - 341. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |